A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses has significantly different effect on which of the following
**Core Concept**
The question tests the understanding of **cholinomimetic agents**, specifically the differences between **physostigmine** and **bethanechol**. These drugs are used to stimulate the parasympathetic nervous system by mimicking the action of **acetylcholine**.
**Why the Correct Answer is Right**
Physostigmine is a **reversible cholinesterase inhibitor**, which increases the concentration of **acetylcholine** in the synaptic cleft by preventing its breakdown. Bethanechol, on the other hand, is a **direct-acting muscarinic receptor agonist**, directly stimulating the muscarinic receptors. The key difference lies in their effect on the **central nervous system (CNS)**, as physostigmine can cross the **blood-brain barrier** and cause CNS effects, whereas bethanechol does not cross the blood-brain barrier and has minimal CNS effects.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, so we cannot assess its accuracy.
**Option B:** This option is not provided, so we cannot assess its accuracy.
**Option C:** This option is not provided, so we cannot assess its accuracy.
**Option D:** This option is not provided, so we cannot assess its accuracy.
**Clinical Pearl / High-Yield Fact**
It's crucial to remember that **physostigmine** can have significant **CNS effects**, such as inducing seizures or coma in high doses, whereas **bethanechol** is generally safer in this regard. This distinction is vital in clinical practice when choosing a cholinomimetic agent.
**Correct Answer:** D. Heart rate